Clinical Trials Directory

Trials / Completed

CompletedNCT02016768

Decompressive Cervical Surgery and Hypertension

Decompressive Cervical Surgery for Antihypertensive Effect in Patients With Cervical Spondylosis and Hypertension-A Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Peking University First Hospital · Academic / Other
Sex
All
Age
18 Years – 84 Years
Healthy volunteers
Not accepted

Summary

There is a relationship between CSM and hypertension, probably a cause/effect relationship, and investigators term this type of hypertension "cervicogenic hypertension". Abnormally functioning serotonergic pacemaker cells in the dorsal raphe nucleus inappropriately activate and inhibit parts of the central and autonomic nervous systems as part of a chronic stress response, which causes hypertension and migraine. This theory is now being expanded to encompass both CSM and essential hypertension, the idea being that these two conditions are intimately related.

Detailed description

Cervical spondylotic myelopathy (CSM) and hypertension are both very common diseases in the general population.Investigators have also observed previously hypertensive patients with CSM become normotensive following decompressive cervical surgery and no longer need antihypertensive medications. Both observations are difficult to explain according to current theories of the two diseases.

Conditions

Interventions

TypeNameDescription
PROCEDUREdecompressive cervical surgeryTo make decompressive cervical surgery, either anterior cervical discectomy and fusion or posterior laminoplasty on the patients suffering from cervical spondylotic myelopathy and hypertension.

Timeline

Start date
2014-06-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2013-12-20
Last updated
2020-01-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02016768. Inclusion in this directory is not an endorsement.